University of California San Francisco
Give to UCSF
UCSF scientists have received two grants from the California Institute for Regenerative Medicine to refine their human embryonic stem cell-based strategies for treating neurological diseases and liver failure.
UCSF will hold a groundbreaking ceremony on Tuesday, October 26 for the new UCSF Medical Center at Mission Bay, a world-class hospital complex for children, women and cancer patients.
An invited commentary in the Oct. 11 <i>Archives of Internal Medicine</i>, titled "A Prescription for Improved Chronic Disease Management,” highlights the current and potential role of pharmacists in preventing and treating chronic diseases.
UCSF Nobel laureate Stanley B. Prusiner, professor of neurology and director of the Institute for Neurodegenerative Diseases, today (Oct. 15, 2010) was named to receive the National Medal of Science, the nation’s highest honor for science and technology.
On Tuesday, October 19, 2010, San Francisco VA Medical Center bone researcher and former NCIRE Board of Directors member Robert A. Nissenson, PhD, will receive the 2010 Shirley Hohl Service Award from the American Society for Bone and Mineral Research (ASBMR).
The UCSF Global Health Group will host a Bay Area Global Health Summit to focus on innovative ways of using technologies to improve global health over the next decade.
UCSF Chancellor Susan Desmond-Hellmann, MD, MPH, will be inducted today into the American Academy of Arts and Sciences, alongside some of the world’s other most distinguished scholars, artists and institutional leaders.
A woman’s race/ethnicity and socioeconomic status impact whether health care providers recommend one of the most highly effective forms of contraception, a UCSF study confirms. The results also indicate that the interaction of both factors plays a role in clinicians’ decisions.
Patients who cannot discuss their diabetes with a doctor in their own language may have poorer health outcomes, even when interpreter services are available, according to a new study by researchers at UCSF and the Kaiser Permanente Division of Research.
A diet supplemented with powdered dried plum restored bone lost by mice during the course of normal aging, in a study led by Bernard P. Halloran, PhD, at the San Francisco VA Medical Center.
The University of California, San Francisco, has named John D. B. Featherstone, PhD, as dean of the UCSF School of Dentistry. The appointment was approved last week by the UC Board of Regents and is retroactive to Sept. 1, 2008.
A particularly aggressive childhood cancer can be fought successfully with far less chemotherapy than previously believed, avoiding harmful side effects caused by cancer drugs.
UCSF research-doctorate programs have ranked among the nation’s best in a survey released today by the National Research Council (NRC).
Surgical patients with known heart disease risks who are given beta blockers around the time of surgery have a significantly reduced risk of post-operative death compared with patients not given beta blockers, according to a study by researchers at the San Francisco VA Medical Center.
Basic physical limitations following breast cancer treatment can have far-reaching consequences that substantially affect how long a patient lives.
The U.S. Department of Justice declined to consent to the University of California’s motion to intervene in Sherley v. Sebelius, the case regarding federal funding for human embryonic stem cell (hESC) research, on which UC had made a motion to the U.S. Federal Court of Appeals on Sept. 20.
Diabetes research is on the cusp of new advances in treatment options and in understanding the underlying causes of both type 1 and type 2 diabetes. Among those are potential treatments using stem cells to regenerate a patient’s ability to produce insulin, as well as upcoming clinical trials of a vaccine that potentially could prevent type 1 diabetes.
Renown Institute for Cancer in Reno and the UCSF Helen Diller Family Comprehensive Cancer Center, the two leading cancer programs in their regions, have joined forces to enhance patient care and improve access to top level medical experts.
The UCSF Diabetes Center will celebrate a decade of advancing research and patient care in diabetes with a scientific symposium featuring the nation’s leaders in the field.
An inexpensive, hundred-year-old therapy for pain – aspirin – is effective in high doses for the treatment of severe headache and migraine caused by drug withdrawal, according to a new study by researchers with the UCSF Headache Center.
Cell biologists at UCSF have received $15.4 million from the National Institutes of Health to set up one of two new National Centers for Systems Biology, to study how cells respond to their environment – an emerging field of research that could revolutionize medicine by creating “smart cells” to deliver medications and other therapeutics more effectively.
The University of California filed a motion Sept. 20 with the U.S. Federal Court of Appeals to intervene in Sherley v. Sebelius, the case regarding whether federal funds could be used for human embryonic stem cell (hESC) research. UC is the nation’s first research institution to formally seek to intervene in the pending lawsuit.
The University of California Board of Regents today unanimously approved funding plans for the new UCSF Medical Center at Mission Bay, clearing the way for UCSF to break ground on a world-class hospital complex for children, women and cancer patients in the Mission Bay neighborhood south of downtown San Francisco.
A method that is widely used to predict the risk of a major coronary event may over- or underestimate risk for millions of Americans, according to a study directed by a researcher at the San Francisco VA Medical Center and the University of California, San Francisco.
UCSF scientists will receive two grants totaling $15.1 million over the next five years to expand their research into how genes affect an individual’s response to medication and to strengthen a global network of researchers involved in these efforts.
UCSF researchers today unveiled a prototype model of the first implantable artificial kidney, in a development that one day could eliminate the need for dialysis.
Ezlopitant, a compound known to suppress craving for alcohol in humans, was shown to decrease consumption of sweetened water by rodents in a study by researchers at the Ernest Gallo Clinic and Research Center, which is affiliated with UCSF.
A celebration of the Zen Hospice Project’s Guest House re-opening and new partnership with UCSF Medical Center.
In a study of elderly Americans who moved to a nursing home for their final months or years of life, 80 percent died there within one year, according to an investigation by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.
A joint project of UCSF and the Kenya Medical Research Institute has received $7 million—the first award of a five year grant that will total about $35 million—to expand its care and support of people affected by HIV/AIDS in Kenya.